PRO-1562 Oral Capsules: Clinical Trials

1 trial of PRO-1562 Oral Capsules, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow PRO-1562 Oral Capsules: new trials by email Literature Review of PRO-1562 Oral Capsules trials Research Report on PRO-1562 Oral Capsules

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis
PRO-1562 Oral Capsules, Placebo Oral Capsule - Multiple Sclerosis
Phase 1 / Phase 2RecruitingProgentos Therapeutics1602026-10-012026-09-29

Conditions studied

Multiple Sclerosis (1)

Sponsors

Progentos Therapeutics (1)

Countries

Australia (1)

Top investigators

Paul A Frohna, MD, PhD, PharmD (1)